# PRX-00023 Therapy in Localization-Related Epilepsy

> **NCT01281956** · PHASE2 · TERMINATED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 12 (actual)

## Conditions studied

- Epilepsy
- Epilepsy, Temporal Lobe
- Partial Epilepsy

## Interventions

- **DRUG:** PRX-00023
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01281956
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-01-07
- **Primary completion:** 2017-10-05
- **Final completion:** 2017-10-05
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2018-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01281956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01281956, "PRX-00023 Therapy in Localization-Related Epilepsy". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01281956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*